Literature DB >> 2194539

New endocrine drugs for treatment of advanced breast cancer.

P E Lønning1.   

Abstract

Current status of endocrine treatment for breast cancer is reviewed. Several new aromatase inhibitors as well as antiestrogens are being introduced for clinical trials. As different drugs within the same drug group may possess different biochemical actions, apart from being useful drugs for treatment of breast cancer, these drugs may also extend our knowledge about the endocrinology of breast cancer.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2194539     DOI: 10.3109/02841869009090018

Source DB:  PubMed          Journal:  Acta Oncol        ISSN: 0284-186X            Impact factor:   4.089


  1 in total

1.  Aminoglutethimide enzyme induction: pharmacological and endocrinological implications.

Authors:  P E Lønning
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.